Testing in a validation cohort of localized PCa (n = 185) revealed that 5/18 DMGs (AC074091, CACNA2D4, MARCH6, PRDM8, and ZNF655) were associated with biochemical recurrence (BCR) and patient survival. Here, ZNF655 is linked to posterior cortical atrophy.